Autonomix Medical, Inc. (AMIX)

Autonomix Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	8.61	8.61	0.87	2.04
Cash & Cash Equivalents	8.61	8.61	0.87	2.04
Cash Growth	-	895.14%	-57.68%	-
Other Current Assets	0.78	0.78	0	0.01
Total Current Assets	9.39	9.39	0.87	2.05
Property, Plant & Equipment	0.02	0.02	0	0
Total Long-Term Assets	0.02	0.02	0	0
Total Assets	9.41	9.41	0.87	2.05
Accounts Payable	0.49	0.49	0.17	0.09
Other Current Liabilities	0.29	0.29	0.05	0
Total Current Liabilities	0.78	0.78	0.22	0.09
Long-Term Debt	1	1	0	0
Total Long-Term Liabilities	1	1	0	0
Total Liabilities	1.78	1.78	0.22	0.09
Total Debt	1	1	0	0
Retained Earnings	-38.97	-38.97	-23.54	-21.55
Shareholders' Equity	7.63	7.63	0.64	1.96
Net Cash / Debt	7.61	7.61	0.87	2.04
Net Cash / Debt Growth	-	779.31%	-57.68%	-
Net Cash Per Share	0.52	0.52	0.07	0.99
Working Capital	8.61	8.61	0.64	1.96
Book Value Per Share	0.52	0.52	0.05	0.95

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).